National Health Investors Statistics
Total Valuation
NHI has a market cap or net worth of $3.52 billion. The enterprise value is $4.63 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | Sep 30, 2025 |
Share Statistics
NHI has 47.47 million shares outstanding. The number of shares has increased by 4.81% in one year.
Current Share Class | 47.47M |
Shares Outstanding | 47.47M |
Shares Change (YoY) | +4.81% |
Shares Change (QoQ) | +2.06% |
Owned by Insiders (%) | 4.21% |
Owned by Institutions (%) | 71.05% |
Float | 45.48M |
Valuation Ratios
The trailing PE ratio is 23.62 and the forward PE ratio is 22.86. NHI's PEG ratio is 5.44.
Price/FFO Ratio | 16.15 |
Price/AFFO Ratio | n/a |
PE Ratio | 23.62 |
Forward PE | 22.86 |
PS Ratio | 9.61 |
Forward PS | 9.47 |
PB Ratio | 2.39 |
P/TBV Ratio | 2.39 |
P/FCF Ratio | n/a |
P/OCF Ratio | 16.63 |
PEG Ratio | 5.44 |
Financial Ratio History Enterprise Valuation
EV / Earnings | 32.46 |
EV / Sales | 13.22 |
EV / EBITDA | 17.09 |
EV / EBIT | 23.68 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37, with a Debt / Equity ratio of 0.75.
Current Ratio | 0.37 |
Quick Ratio | 0.35 |
Debt / Equity | 0.75 |
Debt / EBITDA | 4.12 |
Debt / FCF | n/a |
Interest Coverage | 3.29 |
Financial Efficiency
Return on equity (ROE) is 10.25% and return on invested capital (ROIC) is 4.88%.
Return on Equity (ROE) | 10.25% |
Return on Assets (ROA) | 4.73% |
Return on Invested Capital (ROIC) | 4.88% |
Return on Capital Employed (ROCE) | 8.26% |
Revenue Per Employee | $11.69M |
Profits Per Employee | $4.76M |
Employee Count | 30 |
Asset Turnover | 0.14 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.95% in the last 52 weeks. The beta is 0.76, so NHI's price volatility has been lower than the market average.
Beta (5Y) | 0.76 |
52-Week Price Change | -0.95% |
50-Day Moving Average | 71.50 |
200-Day Moving Average | 72.59 |
Relative Strength Index (RSI) | 56.45 |
Average Volume (20 Days) | 220,453 |
Short Selling Information
The latest short interest is 1.87 million, so 3.93% of the outstanding shares have been sold short.
Short Interest | 1.87M |
Short Previous Month | 2.09M |
Short % of Shares Out | 3.93% |
Short % of Float | 4.11% |
Short Ratio (days to cover) | 7.72 |
Income Statement
In the last 12 months, NHI had revenue of $350.60 million and earned $142.78 million in profits. Earnings per share was $3.14.
Revenue | 350.60M |
Gross Profit | 340.54M |
Operating Income | 195.72M |
Pretax Income | 127.60M |
Net Income | 142.78M |
EBITDA | 271.24M |
EBIT | 195.72M |
Earnings Per Share (EPS) | $3.14 |
Full Income Statement Balance Sheet
The company has $18.64 million in cash and $1.12 billion in debt, giving a net cash position of -$1.10 billion or -$23.18 per share.
Cash & Cash Equivalents | 18.64M |
Total Debt | 1.12B |
Net Cash | -1.10B |
Net Cash Per Share | -$23.18 |
Equity (Book Value) | 1.50B |
Book Value Per Share | 31.17 |
Working Capital | -205.63M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 212.50M |
Capital Expenditures | -4.07M |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 97.13%, with operating and profit margins of 55.82% and 40.77%.
Gross Margin | 97.13% |
Operating Margin | 55.82% |
Pretax Margin | 40.37% |
Profit Margin | 40.77% |
EBITDA Margin | 77.37% |
EBIT Margin | 55.82% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $3.60, which amounts to a dividend yield of 4.86%.
Dividend Per Share | $3.60 |
Dividend Yield | 4.86% |
Dividend Growth (YoY) | 0.56% |
Years of Dividend Growth | n/a |
Payout Ratio | 115.38% |
Buyback Yield | -4.81% |
Shareholder Yield | 0.03% |
Earnings Yield | 4.04% |
FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for NHI is $84.60, which is 14.16% higher than the current price. The consensus rating is "Buy".
Price Target | $84.60 |
Price Target Difference | 14.16% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 18.58% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |